Bullboard - Stock Discussion Forum Bioasis Technologies Inc. V.BTI

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to... see more

Add To Watchlist

TSXV:BTI - Post Discussion

Bioasis Technologies Inc. > Prothena

View:

Post by AlfredSisley on Dec 14, 2020 1:37pm

Prothena

What's going on here with the 3 addtional options? Will the time limit be extended again?

What about the exclusive deal on the undisclosed neurodegenerative disease target?

Should this exclusive licensing deal even be in our pipeline given we've sold milestone payments AND future royalties to XOMA?

229

Comment

Comment by JDavenport on Dec 14, 2020 2:13pm

AlfredSisley, go read the XOMA 10K and Bioasis' reports and PRs, for goodness sakes. YES, PROTHENA SHOULD BE, MUST BE, AND WILL BE CONTAINED WITHIN BIOASIS' REPORTING. Nobody likes tax loss selling. Nobody likes a 28¢ share price. Very few will buy from the offer in December. (No offense, just business.) Shareholder meltdowns are born of ignorance about Bioasis and xB3. They are ...more

232

Comment

Bioasis Technologies Inc.